No­var­tis hus­tles along an­oth­er FDA ap­pli­ca­tion for CAR-T star, tack­ling Gilead head on

Gilead like­ly won’t have DL­B­CL can­cer to it­self in the CAR-T are­na for very long.

No­var­tis put out word ear­ly Tues­day that it has added …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.